摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5,5-dimethyl-3-(2-oxopropyl)tetrahydrofuran-2-one | 1174396-66-7

中文名称
——
中文别名
——
英文名称
5,5-dimethyl-3-(2-oxopropyl)tetrahydrofuran-2-one
英文别名
5,5-dimethyl-(2-oxopropyl)oxolan-2-one;5,5-dimethyl-3-(2-oxopropyl)oxolan-2-one
5,5-dimethyl-3-(2-oxopropyl)tetrahydrofuran-2-one化学式
CAS
1174396-66-7
化学式
C9H14O3
mdl
——
分子量
170.208
InChiKey
XXMDDMCGJHBBOD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.5
  • 重原子数:
    12
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.78
  • 拓扑面积:
    43.4
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    5,5-dimethyl-3-(2-oxopropyl)tetrahydrofuran-2-one氨基硫脲硫酸 作用下, 以 乙醇 为溶剂, 反应 1.0h, 以80%的产率得到5,5-dimethyl-3-(2-thiosemicarbazonopropyl)tetrahydrofuran-2-one
    参考文献:
    名称:
    Synthesis of 5-substituted 3-(2-oxopropyl)tetrahydrofuran-2-ones and heterocyclic compounds on their base
    摘要:
    Alkylation of ethyl 2-oxotetrahydrofuran-3-carboxylates with 2,3-dichloroprop-1-ene and 3-bromoprop-1-yne gave new 3,5,5-tri- and 3,3,5,5-tetrasubstituted tetrahydrofuran-2-ones which were converted into the corresponding 3-(2-oxopropyl)tetrahydrofuran-2-ones. Reactions of the latter with semicarabazide, thiosemicarbazide, and phenylhydrazine were studied with a view to obtain new heterocyclic lactones.
    DOI:
    10.1134/s1070428008120130
  • 作为产物:
    描述:
    5,5-dimethyl-3-(prop-2-yn-1-yl)oxolan-2-one硫酸 、 mercury(II) sulfate 作用下, 反应 6.0h, 以76%的产率得到5,5-dimethyl-3-(2-oxopropyl)tetrahydrofuran-2-one
    参考文献:
    名称:
    Synthesis of 5-substituted 3-(2-oxopropyl)tetrahydrofuran-2-ones and heterocyclic compounds on their base
    摘要:
    Alkylation of ethyl 2-oxotetrahydrofuran-3-carboxylates with 2,3-dichloroprop-1-ene and 3-bromoprop-1-yne gave new 3,5,5-tri- and 3,3,5,5-tetrasubstituted tetrahydrofuran-2-ones which were converted into the corresponding 3-(2-oxopropyl)tetrahydrofuran-2-ones. Reactions of the latter with semicarabazide, thiosemicarbazide, and phenylhydrazine were studied with a view to obtain new heterocyclic lactones.
    DOI:
    10.1134/s1070428008120130
点击查看最新优质反应信息

文献信息

  • Synthesis and transformations of 5,5-disubstituted 3-alkenyloxolan-2-ones
    作者:T. V. Kochikyan、M. A. Samvelyan、A. S. Galstyan、V. M. Muzalevskii、V. G. Nenaidenko
    DOI:10.1134/s1070428016050110
    日期:2016.5
    4,4-disubstituted 2-alkenylbutanolides. By oxidation of the latter with hydrogen peroxide and formic acid diololactones were obtained that in conditions of pinacol-pinacolone rearrangement and oxidation with lead tetraacetate afforded formyl- and epoxybutanolides of new structure.
    通过4,4-二取代的2-(乙羰基)丁醇化物的烷基化,合成了新的4,4-二取代的2-链基-2-(乙羰基)丁醇化物,其在碱性解下形成4,4-二取代的2-链丁醇化物。通过用过氧化氢甲酸对后者进行化,得到了在频哪醇-频哪酮重排和用四乙酸铅化的条件下二甲内,得到了新结构的甲酰基-和环丁醇化物。
  • Inhibitors of transglutaminases
    申请人:Zedira GmbH
    公开号:US11072634B2
    公开(公告)日:2021-07-27
    The invention relates to the compound of general formula (I) as novel inhibitors of transglutaminases, to methods for producing the inventive compounds, to pharmaceutical compositions containing said inventive compounds and to their use for the prophylaxis and treatment of diseases associated with transglutaminases.
    本发明涉及作为新型转谷酰胺抑制剂的通式(I)化合物、生产本发明化合物的方法、含有所述本发明化合物的药物组合物以及它们在预防和治疗与转谷酰胺酶有关的疾病方面的用途。
  • INHIBITORS OF TRANSGLUTAMINASES
    申请人:Zedira GmbH
    公开号:US20190322700A1
    公开(公告)日:2019-10-24
    The invention relates to the compound of general formula (I) as novel inhibitors of transglutaminases, to methods for producing the inventive compounds, to pharmaceutical compositions containing said inventive compounds and to their use for the prophylaxis and treatment of diseases associated with transglutaminases.
  • [EN] INHIBITORS OF TRANSGLUTAMINASES<br/>[FR] INHIBITEURS DE TRANSGLUTAMINASES
    申请人:ZEDIRA GMBH
    公开号:WO2018122419A1
    公开(公告)日:2018-07-05
    The invention relates to the compound of general formula (I) as novel inhibitors of transglutaminases, to methods for producing the inventive compounds, to pharmaceutical compositions containing said inventive compounds and to their use for the prophylaxis and treatment of diseases associated with transglutaminases.
查看更多